Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -249.0% | -176.0% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 13.7 | 10.5 |
Pr/Book | 1.4 |
Latest | F'cast | |
---|---|---|
Revenue | -5.9% | 35.7% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-17 | 1.88 | (0.76) | (0.33)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-18 | 2.77 | (0.53) | (0.16)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 2.05 | (1.48) | (0.55)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 1.37 | (2.55) | (0.66)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.29 | (3.40) | (0.73)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-22 | 1.75 | (3.08) | n/a | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 2.77 | (2.89) | n/a | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Trading Update | 10-Jan-2023 | 07:00 | RNS |
Distribution Agreement for Mevalone in France | 15-Dec-2022 | 07:00 | RNS |
Organic Certification in Greece | 30-Nov-2022 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 4.65p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 6.50 |
52 Week Low | 3.55 |
Volume | 0 |
Shares Issued | 380.86m |
Market Cap | £17.71m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research